The concept of improving animal health through improved gut health has existed in food animal production for decades; however, only recently have we had the tools to identify microbes in the intestine associated with improved performance. Currently, little is known about how the avian microbiome develops or the factors that affect its composition. To begin to address this knowledge gap, the present study assessed the development of the cecal microbiome in chicks from hatch to 28 days of age with and without a live Salmonella vaccine and/or probiotic supplement; both are products intended to promote gut health. The microbiome of growing chicks develops rapidly from days 1–3, and the microbiome is primarily Enterobacteriaceae, but Firmicutes increase in abundance and taxonomic diversity starting around day 7. As the microbiome continues to develop, the influence of the treatments becomes stronger. Predicted metagenomic content suggests that, functionally, treatment may stimulate more differences at day 14, despite the strong taxonomic differences at day 28. These results demonstrate that these live microbial treatments do impact the development of the bacterial taxa found in the growing chicks; however, additional experiments are needed to understand the biochemical and functional consequences of these alterations.

In digesting and absorbing dietary nutrients, the gastrointestinal tract consumes approximately 20% of all incoming energy. A substantial proportion of this consumption is due to the rapid turnover of cellular protein, which permits abrupt changes in gut size to occur, matching capacity with delivery. If it is size of the alimentary tract that constrains nutrient uptake, greater than 20% allocation of ME intake above maintenance to the gut would improve the growth rate of a young animal but the efficiency of ME utilization for growth would deteriorate. Less than 15% allocation in birds seems injurious to both growth rate and efficiency of growth. Nutrient transport capacity of the intestine may be modulated independent of size; in the case of glucose, an up- or down-regulation of the number of brush-border glucose transporters matches absorptive capacity with delivery. The maximum uptake capacity of a small intestine for glucose at any moment in time is a function of its length, the flow rate of digesta, and the distributed-in-space kinetic parameters of transport (e.g., Vmax and Km). An example maximum uptake capacity for glucose in sheep is calculated at 2,112 g/d, assuming continuous digesta flow. Intermittency of flow reduces the uptake capacity to a functional level of 295 g/d, demonstrating a constraining influence of the periodicity of the migrating myoelectric complex. Growth regulation by stimulatory and inhibitory mitotic signals is presented as a candidate for an energy-independent determinant of the upper limit to functional maximum uptake capacity of the small intestine. Both size and functional capacity of the intestine must be considered in assessing the impact this tissue may have on the rest of the animal.

Direct-fed microbials (DFM) could serve as a potential alternative to the feeding of antibiotics in poultry production. In this study, the effects of providing a DFM were compared with the feeding of salinomycin on intestinal histomorphometrics, and microarchitecture was examined. Broiler chicks (n=18 per treatment; trials 1 and 2) were fed a standard starter diet (control), control+PrimaLac (DFM; 0.3% wt/wt), and control+salinomycin (SAL; 50 ppm) from hatch to 21d. The birds were euthanized on d 21, and the ileal, jejunal, cecal, and colon tissues were dissected. Samples were examined by light microscopy (jejunum and ileum; trial 1) and scanning electron microscopy (ileum, cecum, and colon; trial 2). Feeding of the DFM increased intestinal muscle thickness (P<0.05) up to 33% compared with the control treatment. The DFM group also had increased villus height and perimeter (P=0.009 and 0.003, respectively) in jejunum. Segmented filamentous-like bacteria were less numerous in DFM-treated chicks than in the control chicks. Very few segmented filamentous-like bacteria were found near other microbes in the ileum. The DFM chicks had a larger number of bacteria positioned over or near goblet cells and in intervilli spaces. Bacteria in the colon were observed to be attached primarily around and within the crypts. Mucous thickness was less, and the density of bacteria embedded in the mucous blanket appeared to be lower in DFM-treated animals than in the control in all intestinal segments. The birds fed SAL had fewer bacteria and enterocytes in the ileum than in the control-and DFM-treated birds, and they had thicker and fewer microvilli. Because gastrointestinal track colonization by the DFM organisms can prevent the attachment of pathogens to the epithelium, spatial relationships, in this study, demonstrate the functionality of DFM and probiotics in preventing disease. It also supports previous observations that the feeding of salinomycin may alter intestinal function.

The history of "slobbers syndrome," a mycotoxicosis associated with Rhizoctonia leguminicola infestation of pastures and stored forages, is discussed. The chemistry and physiological effects of the two known biologically active alkaloids of R. leguminicola, slaframine and swainsonine, are described. Slaframine administration is generally associated with increased exocrine function, especially salivation. Ingestion of swainsonine may be linked to serious and potentially lethal central nervous system defects similar to that described for locoism. However, the singular effects of these alkaloids do not completely account for the total clinical picture noted in the field during the occurrence of slobbers syndrome. It is possible that this phenomenon is the result of an interaction between both known and unidentified biologically active metabolites of R. leguminicola.

Growing steers were used in a replicated 3 X 3 Latin square to study the influence of ionophores on mineral metabolism and ruminal urease activity. Treatments consisted of: 1) basal high energy diet; 2) basal plus 33 ppm lasalocid and 3) basal plus 33 ppm monensin. Each period was 33 days and apparent absorption and retention of macrominerals were measured during the last 5 days of each period. Mineral intake during the collection period was not affected by treatment. Both ionophores increased apparent absorption of sodium, magnesium and phosphorus. Retention of magnesium and phosphorus were higher for steers receiving either lasalocid or monensin. Potassium and calcium absorption were not significantly affected by treatment. Serum concentrations of macrominerals were similar for all treatments. Zinc and copper concentrations in serum were higher in animals fed monensin or lasalocid. Steers fed either ionophore had lower concentrations of soluble potassium and calcium in rumen fluid. Both ionophores also decreased ruminal osmolality. Bacterial urease, a nickel-dependent enzyme, was decreased by 28 and 66% in animals that received lasalocid and monensin, respectively. These findings indicate that lasalocid and monensin affect metabolism of certain minerals in ruminants.

No abstract

No abstract

Terminal hydrolysis of oligosaccharides at the small intestinal brush border yields monomeric glucose, most of which is then absorbed by the transepithelial route. This involves carrier-mediated processes requiring specialized functional proteins situated in the brush border (SGLT1) and basolateral (GLUT2) membranes. Glucose translocation at the enterocyte apical membrane is an active, Na(+)-dependent and saturable process, whereas exit from enterocytes is by facilitated diffusion and is energy-independent. Specific adaptation of glucose active transport occurs in response to changes in the proportion of glucose in the diet. The regulatory signals responsible for transport induction are imprecisely defined, although numerous protein hormones and gut regulatory proteins are implicated. Epidermal growth factor and peptide YY invoke up-regulation of jejunal active glucose transport in vivo. Recently, peptide YY has been shown to stimulate active glucose transport in mice without altering oxygen consumption of jejunal tissue. Several other peptides whose presence in tissues of the small bowel imply that they exert control over epithelial nutrient transport are considered, and the relevance of these physiological manipulations, with various regulatory peptides and hormones, to animal agriculture are discussed.